Your session is about to expire
← Back to Search
Ceftaroline for Cystic Fibrosis
Study Summary
This trial is testing a new way to give the antibiotic ceftaroline to kids with cystic fibrosis who also have a history of methicillin-resistant Staphylococcus aureus (MRSA), also known as oxacillin-resistant Staphylococcus aureus (ORSA).
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there any enrolling opportunities still available for participants in this research?
"This particular clinical trial, as indicated by the website clinicaltrials.gov, is not presently looking for patients to enroll. However, 437 other medical studies are currently recruiting individuals."
How many people are being recruited for this research project?
"Currently, this trial is not searching for new participants. The original posting date was September 1st, 2017 and the most recent update to the listing was on August 29th, 2022. For patients looking for similar studies, there are 433 clinical trials enrolling patients with cystic fibrosis and 4 different trials testing this treatment that are actively recruiting."
Does this research require participants to be a certain age?
"The target age range for patients in this study are those that have turned 2 years old, but are not yet 21."
Can you tell me about any other research that has been conducted on this therapy?
"Currently, 4 clinical trials are underway with 1 in Phase 3. These global studies are being conducted at 329 different locations, with a significant portion taking place in Morgantown, West virginia."
Has this medication been cleared by the FDA?
"This is a Phase 4 trial, meaning that the safety of this treatment has been approved by our team at Power with a score of 3."
Share this study with friends
Copy Link
Messenger